CISION PRNewswire

64022 posts
Victory Securities Partners with Matrixport to Provide Institutional-Grade Asset Security Services for Licensed Virtual Assets Products

Victory Securities Partners with Matrixport to Provide Institutional-Grade Asset Security Services for Licensed Virtual Assets Products

SINGAPORE, March 6, 2024 /PRNewswire/ — Victory Securities, a leading virtual asset…
Omdia: In-cell touch TFT LCD displays in automotive CSD application will become dominant, reaching over 50% shipment share in 2025

Omdia: In-cell touch TFT LCD displays in automotive CSD application will become dominant, reaching over 50% shipment share in 2025

LONDON, March 6, 2024 /PRNewswire/ — While shipment growth for touch displays…
Agoda partners with DBS and launches new rewards points redemption feature

Agoda partners with DBS and launches new rewards points redemption feature

Great value travel just got even easier SINGAPORE, March 6, 2024 /PRNewswire/…
Pentera Launches First-Ever Automated Cloud Penetration Testing Product to Reduce Exposure to Cloud-Native Attacks

Pentera Launches First-Ever Automated Cloud Penetration Testing Product to Reduce Exposure to Cloud-Native Attacks

Pentera’s platform now discovers and prioritizes exploitable security gaps across both cloud…
Study Reveals Annual Cost of Financial Crime Compliance Totals Billion in Asia Pacific

Study Reveals Annual Cost of Financial Crime Compliance Totals $45 Billion in Asia Pacific

True Cost of Financial Crime Compliance Study Reveals Organizations Prioritizing Cost Reduction…
Circulate Capital Chooses SS&C for Fund Administration

Circulate Capital Chooses SS&C for Fund Administration

Leading ESG investor Circulate Capital appoints SS&C as fund administrator to advance…
Everest Medicines to Announce Full-Year 2023 Financial Results on March 28, 2024

Everest Medicines to Announce Full-Year 2023 Financial Results on March 28, 2024

SHANGHAI, March 6, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, "Everest", or…
AACR 2024 | Ascentage Pharma to Present Three Preclinical Studies at 2024 American Association of Cancer Research Annual Meeting

AACR 2024 | Ascentage Pharma to Present Three Preclinical Studies at 2024 American Association of Cancer Research Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, March 6, 2024 /PRNewswire/ — Ascentage Pharma…